The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
800
EFFICACY AND SAFETY OF SUBCUTANEOUS GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS THROUGH WEEK 24 FROM THE PHASE 3 ASTRO STUDY
Date
May 5, 2025
Explore related products in the following collection: